Medical Products Support and Advanced Concept Development

Abstract

Guidance for Development of the Force (GDF) - Medical Products Support and Advanced Concept Development: funding is for product support and advanced concept development of medical products that are regulated by the US Food and Drug Administration (FDA); the transition of FDA-licensed and unregulated products and medical practice guidelines to the military operational user through clinical and field validation studies; prototyping, risk reduction and product transition efforts for medical information technology applications, such as coordination with the Program Execution Office for possible integration into the Military Health System; and medical simulation and training system technologies. The resulting advanced development portfolio is designed to address the following: areas of interest to the Secretary of Defense regarding Wounded Warriors, capabilities identified through the Joint Capabilities Integration and Development System and the strategy and initiatives described in the Quadrennial Defense Review. Program development and execution is peer-reviewed and fully coordinated with all of the Military Services, appropriate Defense Agencies or Activities, and other federal agencies to include the Department of Veterans Affairs, the Department of Health and Human Services, and the Department of Homeland Security. This coordination occurs through the planning and execution activities of the Defense Medical Research and Development Program’s Joint Program Committees, established to manage research, development, test and evaluation for the Defense Health Program (DHP). Research supported by this program element includes transition of medical training and health information sciences; advanced development of rapid pathogen (infectious agent) detection in fresh whole blood; field assessment of intervention tools for post traumatic stress disorder (PTSD); and clinical trials on biomarkers (biological indicators) for traumatic brain injury (TBI) and spinal cord injury, combat casualty care advanced product development, and rehabilitative medicine. As the research efforts mature, the most promising efforts will transition to medical products and support systems development funding, Program Element 0605145. The Army Medical Command received DHP Congressional Special Interest (CSI) research funding focused on Peer-Reviewed Traumatic Brain Injury and Psychological Health Research, and Peer-Reviewed Joint Warfighter Medical Research. Because of the CSI annual structure, out-year funding is not programmed.

Open PDF

Document Details

Document Type
R2 Budgetary Justification
Publication Date
Oct 01, 2015
Source ID
0604110HP_2_0130_PB_2015
Change Summary Explanation
FY 2013: Realignment from Defense Health Program, Research, Development, Test and Evaluation (DHP RDT&E), PE 0604110-Medical Products Support and Advanced Concept Development (-$8.378 million) to DHP RDT&E PE 0605502-Small Business Innovation Research (SBIR) Program (+$8.378 million). FY 2013: Congressional Special Interest (CSI) additions to DHP RDT&E, PE 0604110-Medical Products Support and Advanced Concept Development (+$43.712 million). FY 2013: General Congressional Reductions to DHP RDT&E, PE 0604110-Medical Products Support and Advanced Concept Development (-$0.259 million). FY 2013: Congressional Directed Reductions (Sequestration) to DHP RDT&E, PE 0604110-Medical Products Support and Advanced Concept Development (-$15.897 million). FY 2013: Below Threshold Reprogramming (BTR) from DHP RDT&E PE, 0604110-Medical Products Support and Advanced Concept Development (-$0.124 million) to DHP RDT&E PE, 0603002-Advanced Technology (AFRRI) (+$0.124 million). FY 2013: Below Threshold Reprogramming (BTR) from DHP RDT&E PE, 0604110-Medical Products Support and Advanced Concept Development (-$2.740 million) to DHP RDT&E PE, 0606105-Medical Program-Wide Activities (+$2.740 million). FY 2014: Congressional Special Interest (CSI) Additions to DHP RDT&E, PE 0604110-Medical Products Support and Advanced Concept Development (+$49.000 million). FY 2014: Realignment from Defense Health Program, Research, Development, Test and Evaluation (DHP RDT&E), PE 0604110-Medical Products Support and Advanced Concept Development (-$3.705 million) to DHP RDT&E PE 0605502-Small Business Innovation Research (SBIR) Program (+$3.705 million). FY 2015: Reduces non-combat injury research funding in order to focus and continue the pace of progress in critical and high priority research areas for DHP RDT&E, PE 0604110-Medical Products Support and Advanced Concept Development ($-48.823 million).
Service Agency Name
Defense Health Program

Tags

DTIC Thesaurus Topics

  • Anxiety Disorders
  • Brain Injuries
  • Casualties
  • Combat Casualty Care
  • Combat Injuries
  • Department Of Veterans Affairs
  • Health Services
  • Information Systems
  • Medical Personnel
  • Military Medicine
  • Pain Management
  • Test And Evaluation
  • Therapy
  • Traumatic Stress Disorder
  • Wound Infections

Fields of Study

  • Medicine

Readers

  • Defense Technology Research and Development.
  • Medical or Health Care Field.
  • Military Science and Technology Research and Modernization.

Related Documents